Cell Signaling Technology

IMP1 Antibody

#2852 · $317

100
Citing papers
17.1k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer14Ubiquitin and proteasome pathways11Protein Degradation and Inhibitors10Multiple Myeloma Research and Treatments8MicroRNA in disease regulation7Cancer-related molecular mechanisms research6Polyamine Metabolism and Applications5Chronic Lymphocytic Leukemia Research5

Papers citing this product

1
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
PLoS Biology·2009·1.1k cit.·DOI
2
Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine
Nature·2012·935 cit.·DOI
3
Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling
Genes & Development·2008·696 cit.·DOI
4
Circadian control of brain glymphatic and lymphatic fluid flow
Nature Communications·2020·637 cit.·DOI
5
Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A
Stem Cell Research & Therapy·2018·473 cit.·DOI
6
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu
Blood·2007·472 cit.·DOI
7
The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers
Nature Communications·2017·436 cit.·DOI
8
Human heart-forming organoids recapitulate early heart and foregut development
Nature Biotechnology·2021·433 cit.·DOI
9
Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control
Nature Cell Biology·2005·377 cit.·DOI
10
Inhibition of double‐strand DNA‐sensing cGAS ameliorates brain injury after ischemic stroke
EMBO Molecular Medicine·2020·287 cit.·DOI

Similar products

ProductVendorPricePapers
IMP1 (D33A2) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$157100
IMP1 Antibody — Evidence — PubIndex